Dr. Bobbak Mansouri, MD

Dr. Mansouri practices at Complete Dermatology in Sugarland, Texas.

Dr. Mansouri's NPI, 1053604389, was assigned on May 19, 2011. Dr. Mansouri graduated from Duke University School Of Medicine in 2011. Dr. Mansouri holds Texas license P6025.

Dr. Mansouri's primary practice is Complete Dermatology, at 7616 Branford Pl, Sugarland, TX 77479 in Fort Bend County. The practice phone is (281) 857-6870.

Dr. Mansouri's primary practice is Complete Dermatology in Sugarland, Texas. The medical group on file is Complete Dermatology. Dmand AI also links Dr. Mansouri to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mansouri practices. Vendor and product names are available with a free account.

Dermatology is Dr. Mansouri's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mansouri is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mansouri's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and joint cyst among the conditions Dr. Mansouri treats.

CMS data shows 5,405 Medicare services from Dr. Mansouri across 29 procedure codes in 2024, for 808 Medicare patients. Medicare paid $219,734 for them. Every service was in an office.

CMS counts 808 Medicare patients who saw Dr. Mansouri in 2024. The largest group is 65 to 74, with 489 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mansouri's median patient age at 67, with 40% women.

In 2024, Dr. Mansouri wrote 1,565 Medicare Part D claims for 561 patients. 94% of them were for generic drugs. CMS names the drug for 1,418 of them, across 25 drugs with 11 or more claims each, at $752,352 in total drug cost. In 2023, CMS named 1,127 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mansouri for performance year 2024, reported individually. Dr. Mansouri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,598 procedures of removal of skin lesions by Dr. Mansouri, more than 97% of the clinicians it reports for that procedure.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Mansouri, published from 2006 to 2019. 2015 was the busiest year, with 4. The most frequent topics are Psoriasis, Antibodies, Monoclonal and Mohs Surgery. Dr. Mansouri has published most often in Dermatol Ther (Heidelb). Dr. Mansouri's most frequent co-authors are Dario Nicolas Kivelevitch, MD, Molly T. Campa, MD and Chad D. Housewright, MD.

CMS Open Payments shows 955 general payments to Dr. Mansouri from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $3,644.

Dr. Mansouri graduated from Duke University School Of Medicine in 2011. Dr. Mansouri is a member of AAD.

Dr. Mansouri is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.